Optiver Holding
AQST icon

Optiver Holding’s Aquestive Therapeutics AQST Stock Holding History

Optiver Holding’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.46K Sell
350
-638
-65% -$2.69K ﹤0.01% 2400
2026
Q1 		$4.1K Buy
988
+576
+140% +$2.34K ﹤0.01% 1511
2025
Q4 		$2.66K Buy
412
+76
+23% +$474 ﹤0.01% 1846
2025
Q3 		$1.88K Buy
+336
New +$1.45K ﹤0.01% 2400

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Optiver Holding's AQST Position: Q2 2026 in Review

Optiver Holding reduced its Aquestive Therapeutics (AQST) stake by 65% in Q2 2026, selling an estimated $2.69K and leaving 350 shares worth $1.46K. The position accounts for ﹤0.01% of the portfolio, ranked #2400.

Optiver Holding first reported a position in AQST in Q3 2025 and has held it in 4 quarters since. The position peaked at $4.1K in Q1 2026. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • Optiver Holding held 350 shares of Aquestive Therapeutics worth $1.46K as of Q2 2026.
  • Optiver Holding sold 638 Aquestive Therapeutics shares in Q2 2026, an estimated $2.69K.
  • Aquestive Therapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2400 holding.
  • Optiver Holding first reported a position in Aquestive Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's Aquestive Therapeutics position peaked at $4.1K in Q1 2026.
  • 184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.